Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)

Inclusion Criteria: * Covid-19 positive by polymerase chain reaction (PCR) testing; * Participant must be able to evaluate their symptoms and report them in the symptoms diary; * Patients must be able to take their oral temperature daily with an electronic thermometer provided to them with study materials; * Males and females, at least 18 years of age, capable and willing to provide informed consent; * Female patient is either not of childbearing potential, defined as postmenopausal for at least 1 year or surgically sterile, or is of childbearing potential and practicing at least one method of contraception and preferably two complementary forms of contraception including a barrier method (e.g. male or female condoms, spermicides, sponges, foams, jellies, diaphragm, intrauterine device (IUD)) throughout the study; * Patient must have received a diagnosis of COVID-19 infection within the last 48 hours and have one or more symptoms; * Outpatient setting (not currently hospitalized or under immediate consideration for hospitalization); * Patient must be able and willing to comply with the requirements of this study protocol. Exclusion Criteria: * Patient currently hospitalized or under immediate consideration for hospitalization; * Patient currently in shock or with hemodynamic instability; * Patient undergoing chemotherapy for cancer; * Patient is unable to take oral temperature using an electronic thermometer; * Patient who received at least one dose of the COVID-19 vaccine…